14 Recruiting Systemic Lupus Erythematosus Phase 1 Clinical Trials
Active phase 1 studies for systemic lupus erythematosus enrolling across the USA. Verify eligibility and contact site coordinators.
All Systemic Lupus Erythematosus studiesPhase 1 Studies for Systemic Lupus Erythematosus
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
📍 Keck School of Medicine of University of Southern California — Los Angeles, California
View Study & Checklist ➔A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus
📍 Clinica De La Costa — Barranquilla,
View Study & Checklist ➔A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
📍 Local Institution - 0035 — Aurora, Colorado
View Study & Checklist ➔REACT-01: Reversing Autoimmunity Through Cell Therapy
📍 Seattle Children's Hospital — Seattle, Washington
View Study & Checklist ➔A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
📍 Gold Coast University Hospital ( Site 1601) — Southport, Queensland
View Study & Checklist ➔A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
📍 Climb Bio Investigative Site #100104 — Allen, Texas
View Study & Checklist ➔A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
📍 Pinnacle Research Group /ID# 278677 — Anniston, Alabama
View Study & Checklist ➔Alnuctamab for Refractory SLE (LATTE Study)
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
📍 Research Site — Anniston, Alabama
View Study & Checklist ➔A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
📍 GSK Investigational Site — Scottsdale, Arizona
View Study & Checklist ➔A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
📍 GSK Investigational Site — Buenos Aires,
View Study & Checklist ➔RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
📍 University of California Irvine — Orange, California
View Study & Checklist ➔BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
📍 Nationwide Children's — Columbus, Ohio
View Study & Checklist ➔